Resident CD3+ T?cells in normal skin were negative for all those exhaustion markers. elevated YY1 and Ezh2 in melanoma tumor-infiltrating lymphocytes and in PD1+ T?cells in patients with HIV. Exhaustion is usually revealed to be an active process as the culmination of repetitive two-signal stimulation in a feedback loop via CD3/CD28p38MAPK/JNKYY1 exhaustion. with two signals leads to abundant interleukin-2 (IL-2) production on initial antigen exposure, which abruptly declines on repeated stimulation with concomitant slowing of T?cell proliferation (Emtage et?al., 2008). As a type I cytokine, IL-2 plays a pivotal role in clonal expansion and persistence of virus- and tumor-reactive T?cells and in their effector activity (Rosenberg et?al., 1985, Liao et?al., 2013). The exhibited therapeutic benefit of exogenously supplemented IL-2 in humans and in model systems of cancer and infections is usually one indicator of this impact of exhaustion that hampers T?cells’ ability to generate this same effector molecule (Rosenberg et?al., 1985, Blattman et?al., 2003, Emtage et?al., 2008, Lo et?al., 2010, Liao et?al., 2013). Similarly, the effectiveness of antibodies against the checkpoint receptors to restore T?cell function and generate clinical responses is additional testimony to the relevance of exhaustion to clinical disease (Barber et?al., 2006, Nguyen and Ohashi, 2015). Lastly, there has been an appreciation that a therapeutic synergy Salmefamol may be derived by concurrently addressing the two axes of cytokines and checkpoint receptors (West et?al., 2013). Despite advances in the molecular and phenotypic characterization of exhausted T?cells, the mechanisms underlying the initiation, progression, and maintenance of exhaustion are largely unknown. We exploited our observation of a depressed IL-2 response under repeated stimulation as a potential entre to the exhaustion process to interrogate its molecular basis. Results Exhaustion Model Exhaustion is an system to recapitulate the process. Building on our prior observations (Emtage et?al., 2008), we established a procedure whereby normal resting human T?cells were continuously exposed to signal 1?+ 2 with anti-CD3/CD28 beads, repeated at 2-day intervals, which was previously shown to stimulate and then lose?the production of IL-2 (Figure?1A). This pattern of cytokine failure was confirmed in Rabbit polyclonal to AMACR the current model?for both IL-2 and interferon (IFN) Salmefamol (Figures 1B and S1). Upon repeated stimulation, CD4 and CD8 T?cells also expressed markers of exhaustion, namely, checkpoint receptors PD1, Tim3, and Lag3, which progressively increased with each stimulation (Figure?1C). The cells maintained viability during these stimulations and sustained CD69 expression, a marker of T?cell activation (Figure?S2). Marker progression was independent of IL-2 depletion, as the same results were obtained with 330 IU/mL of exogenously supplemented IL-2 (Figure?S3). Lastly, repeated stimulation of T?cells with immobilized anti-CD3 or anti-CD28 antibody alone was insufficient to induce exhaustion (Figures S4A and S4B), confirming a key distinction from other processes such as anergy in which isolated signal 1 is effective (Appleman and Boussiotis, 2003, Balkhi et?al., 2015). Taken together, this model mimics persistent stimulation of T?cells entering into an antigen-rich environment and successfully recapitulates key features of the exhaustion phenotype. For economy of nomenclature/terminology, we provisionally denote such repeatedly stimulated T?cells as exhausted, with the final judgment reserved for additional confirmations stated below. Open in a separate window Figure?1 Persistent T Cell Activation Induces IL-2 Shutdown and Checkpoint Receptor Elevation (A) Schematic depicting repeat stimulation model. T?cells were stimulated with anti-CD3/CD28 beads for 2?days; cells were counted at the end of 2?days, beads removed, and cells placed in new medium with fresh beads for the next stimulation. Control cells were cultured identically without beads. (B) ELISA shows high secretion and then decline of IL-2 production after repeated stimulations. (C) Flow cytometry of re-stimulated CD4 T?cells analyzed at day 8 shows increasing expression of exhaustion markers, PD1, Lag3, and Tim3. CD8 T?cells exhibited same pattern (data not shown). Similar results were obtained when the cells were analyzed right after first, second, third, and fourth stimulations. (D) qRT-PCR and (E) IL-2 promoter luciferase assay in CD4 T?cells shows fold change of IL-2 mRNA and promoter Salmefamol activity after re-stimulations. Four replicates performed per assay; data from one of three representative experiments. *p? 0.05. YY1 Recruits Ezh2 to Repress IL-2 The IL-2 secretion pattern was paralleled.